These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 35707677)
1. The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD. Leen NA; de Weijer AD; van Rooij SJH; Kennis M; Baas JMP; Geuze E Chronic Stress (Thousand Oaks); 2022; 6():24705470221107290. PubMed ID: 35707677 [TBL] [Abstract][Full Text] [Related]
2. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186 [TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. Hauer D; Schelling G; Gola H; Campolongo P; Morath J; Roozendaal B; Hamuni G; Karabatsiakis A; Atsak P; Vogeser M; Kolassa IT PLoS One; 2013; 8(5):e62741. PubMed ID: 23667516 [TBL] [Abstract][Full Text] [Related]
4. Circulating endocannabinoids and psychological outcomes in women with PTSD. Botsford C; Brellenthin AG; Cisler JM; Hillard CJ; Koltyn KF; Crombie KM J Anxiety Disord; 2023 Jan; 93():102656. PubMed ID: 36469982 [TBL] [Abstract][Full Text] [Related]
5. Depressive symptoms are negatively associated with hair N-arachidonoylethanolamine (anandamide) levels: A cross-lagged panel analysis of four annual assessment waves examining hair endocannabinoids and cortisol. Walther A; Kirschbaum C; Wehrli S; Rothe N; Penz M; Wekenborg M; Gao W Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110658. PubMed ID: 36252885 [TBL] [Abstract][Full Text] [Related]
6. Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder - a pilot study. Wingenfeld K; Dettenborn L; Kirschbaum C; Gao W; Otte C; Roepke S Stress; 2018 Jul; 21(4):366-369. PubMed ID: 29546791 [TBL] [Abstract][Full Text] [Related]
7. Childbirth-related posttraumatic stress symptoms - examining associations with hair endocannabinoid concentrations during pregnancy and lifetime trauma. Bergunde L; Karl M; Schälicke S; Weise V; Mack JT; von Soest T; Gao W; Weidner K; Garthus-Niegel S; Steudte-Schmiedgen S Transl Psychiatry; 2023 Oct; 13(1):335. PubMed ID: 37907467 [TBL] [Abstract][Full Text] [Related]
8. Sex-dependent effects of endocannabinoid modulation of conditioned fear extinction in rats. Morena M; Nastase AS; Santori A; Cravatt BF; Shansky RM; Hill MN Br J Pharmacol; 2021 Feb; 178(4):983-996. PubMed ID: 33314038 [TBL] [Abstract][Full Text] [Related]
9. Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort. deRoon-Cassini TA; Bergner CL; Chesney SA; Schumann NR; Lee TS; Brasel KJ; Hillard CJ Transl Psychiatry; 2022 Feb; 12(1):48. PubMed ID: 35105857 [TBL] [Abstract][Full Text] [Related]
10. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696 [TBL] [Abstract][Full Text] [Related]
11. Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis. Bassir Nia A; Gibson CL; Spriggs SA; Jankowski SE; DeFrancisco D; Swift A; Perkel C; Galynker I; Honrao C; Makriyannis A; Hurd YL J Psychopharmacol; 2023 May; 37(5):484-489. PubMed ID: 36633290 [TBL] [Abstract][Full Text] [Related]
12. Differential effect of interferon-alpha treatment on AEA and 2-AG levels. Zajkowska Z; Borsini A; Nikkheslat N; Russell A; Romano GF; Tomassi S; Hepgul N; Forton D; Agarwal K; Hotopf M; Mondelli V; Zunszain P; Pariante CM Brain Behav Immun; 2020 Nov; 90():248-258. PubMed ID: 32860939 [TBL] [Abstract][Full Text] [Related]
13. Masturbation to Orgasm Stimulates the Release of the Endocannabinoid 2-Arachidonoylglycerol in Humans. Fuss J; Bindila L; Wiedemann K; Auer MK; Briken P; Biedermann SV J Sex Med; 2017 Nov; 14(11):1372-1379. PubMed ID: 29110806 [TBL] [Abstract][Full Text] [Related]
14. Evidence for altered brain reactivity to norepinephrine in Veterans with a history of traumatic stress. Hendrickson RC; Raskind MA; Millard SP; Sikkema C; Terry GE; Pagulayan KF; Li G; Peskind ER Neurobiol Stress; 2018 Feb; 8():103-111. PubMed ID: 29888305 [TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids, Anandamide and 2-Arachidonoylglycerol, as Prognostic Markers of Sepsis Outcome and Complications. Šahinović I; Mandić S; Mihić D; Duvnjak M; Loinjak D; Sabadi D; Majić Z; Perić L; Šerić V Cannabis Cannabinoid Res; 2023 Oct; 8(5):802-811. PubMed ID: 35649233 [No Abstract] [Full Text] [Related]
16. Pretreatment cortisol predicts trauma-focused psychotherapy response in youth with (partial) posttraumatic stress disorder. Zantvoord JB; Ensink JBM; Op den Kelder R; Wessel AMA; Lok A; Lindauer RJL Psychoneuroendocrinology; 2019 Nov; 109():104380. PubMed ID: 31352130 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoid polymorphisms interact with plasma endocannabinoid levels to predict fear extinction learning. Ney LJ; Matthews A; Hsu CK; Zuj DV; Nicholson E; Steward T; Nichols D; Graham B; Harrison B; Bruno R; Felmingham K Depress Anxiety; 2021 Oct; 38(10):1087-1099. PubMed ID: 34151472 [TBL] [Abstract][Full Text] [Related]
18. Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans. Feuerecker M; Hauer D; Gresset T; Lassas S; Kaufmann I; Vogeser M; Briegel J; Hornuss C; Choukèr A; Schelling G Alcohol Alcohol; 2012; 47(3):226-32. PubMed ID: 22278319 [TBL] [Abstract][Full Text] [Related]
19. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Hill MN; Miller GE; Ho WS; Gorzalka BB; Hillard CJ Pharmacopsychiatry; 2008 Mar; 41(2):48-53. PubMed ID: 18311684 [TBL] [Abstract][Full Text] [Related]